First, the Kras mutation rate is highly prevalent in both CRC and PDAC: the functional mutation rate of Kras in CRC is at a range of 40%–44.7%76, 77 and in PDAC is at a range of 70%–90%.78, 79. The gene discussed is KRAS; the disease is colorectal carcinoma.